biology-technology-1/pericor-therapeutics-reports-positive-preclinical-results-of-gp531-at-the-european-heart-failure-congress-in-nice-12443-3/;msg90356
| We're sorry, that page (http://www.bio-medicine.org/biology-technology-1/pericor-therapeutics-reports-positive-preclinical-results-of-gp531-at-the-european-heart-failure-congress-in-nice-12443-3/;msg90356) was not found. Search biology technology 1 pericor therapeutics reports positive preclinical results of gp531 at the european heart failure congress in nice 12443 3 ;msg90356 at Google Search biology technology 1 pericor therapeutics reports positive preclinical results of gp531 at the european heart failure congress in nice 12443 3 ;msg90356 at Yahoo Search biology technology 1 pericor therapeutics reports positive preclinical results of gp531 at the european heart failure congress in nice 12443 3 ;msg90356 at Msn |
Breaking Biology Technology:Technology, Biotech, Energy and Transportation Among the Industries to be Featured at Sidoti & Company's First Annual 2010 Micro Cap Conference 2China Biologic Products to Ring NASDAQ Opening Bell 2China Biologic Products to Ring NASDAQ Opening Bell 3Martek Signs Sole-Source Supply Agreement with Fonterra 2Martek Signs Sole-Source Supply Agreement with Fonterra 3Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 2Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 3
[0] Technology, Biotech, Energy and Transportation Among the Industries to be Featured at Sidoti & Company's First Annual 2010 Micro Cap Conference[0] China Biologic Products to Ring NASDAQ Opening Bell[0] Martek Signs Sole-Source Supply Agreement with Fonterra[0] Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years
Breaking Medicine Technology:Circassia Raises GBP15 Million ($25 Million) in Oversubscribed Investment Round 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5Obesity While Young Boosts Pancreatic Cancer Risk 49819 1Obesity While Young Boosts Pancreatic Cancer Risk 49819 2Obesity While Young Boosts Pancreatic Cancer Risk 49819 3Lifeclinic Teams Up With Trucking Industry to Promote Health and Wellness to Over the Road Professionals 49815 1Lifeclinic Teams Up With Trucking Industry to Promote Health and Wellness to Over the Road Professionals 49815 2Lifeclinic Teams Up With Trucking Industry to Promote Health and Wellness to Over the Road Professionals 49815 321st Century Obesity Pandemic Still Suffering From Effects of Tuberculosis Plague of the 1800s 49811 121st Century Obesity Pandemic Still Suffering From Effects of Tuberculosis Plague of the 1800s 49811 221st Century Obesity Pandemic Still Suffering From Effects of Tuberculosis Plague of the 1800s 49811 321st Century Obesity Pandemic Still Suffering From Effects of Tuberculosis Plague of the 1800s 49811 4
[0] Circassia Raises GBP15 Million ($25 Million) in Oversubscribed Investment Round[0] Boston Scientific Announces Pricing of $2 Billion of Senior Notes[0] Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy
| Copyright © 2003-2007 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |